| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |